09 May 2024
09 May 2024
Coinfections can complicate disease management and hence continued surveillance and targeted intervention strategies are needed.
The centre of gravity in the pharmaceutical industry is changing. But one common factor can help make supply chains more comprehensible, resilient and valuable: data
ECUR-506 is being evaluated in the first-in-human Phase I/II OTC-HOPE study.
The approval for Aspaveli's extended indication is based on data from the APL2-308 (PRINCE) study.
At the London Biotechnology Show, Microsoft’s senior director of life sciences discussed the ethical use of GenAI.
Zenas signed a licensing deal for Asia-Pacific territories for the bispecific antibody therapy, obexelimab, with Bristol Myers Squibb in September 2023.
The project aims to create models that can predict the way medicines are released from IR tablets.
The total investment by the fund since 2013 is Y33.2bn.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
